Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(5 sites)

United States

University of California San Francisco, San Francisco, California

Children's National Medical Center, Washington D.C., District of Columbia

Maine Medical Center, Scarborough, Maine

Primary Children's Hospital, Salt Lake City, Utah

University of Utah, Salt Lake City, Utah